Since 2025, electronic instructions for use (eIFU) are no longer limited to a handful of product families. Implementing Regulation (EU) 2021/2226, as amended by Implementing Regulation (EU) 2025/1234, allows instructions for use to be supplied in electronic form for any device intended exclusively for professional users. The opening is real, but it comes with conditions. Going digital is not a matter of posting a PDF on a website and printing a web address on the packaging. Here are the points we check in an eIFU file.
What electronic instructions for use (eIFU) cover under Regulation 2021/2226
The basis sits in Regulation (EU) 2017/745 (MDR), Annex I, Chapter III, Section 23.1: instructions for use may be provided in a non-paper format only to the extent, and under the conditions, set out in the implementing rules. Those rules are now the ones in Implementing Regulation (EU) 2021/2226 of 14 December 2021, which repealed Regulation (EU) No 207/2012.
The original scope was narrow: implantable and active implantable devices and their accessories, fixed installed devices, devices fitted with a built-in display system, and software. Implementing Regulation (EU) 2025/1234 of 25 June 2025, in force since 16 July 2025, replaced that list with a single criterion, the user. Electronic instructions are available for devices intended exclusively for professional users, including the products without an intended medical purpose listed in Annex XVI to the MDR.
Two caveats are worth keeping in mind. Where use by a lay person is reasonably foreseeable, paper instructions are still owed to that audience. For software, the electronic form is accepted even outside professional use, provided the instructions are delivered through the software itself.
The IVD case
In vitro diagnostic medical devices do not fall under Regulation 2021/2226. Regulation (EU) 2017/746 (IVDR) settles the point directly, in Annex I, Section 20.1: instructions may be supplied in a non-paper format where the device is intended for professional use, with the exception of near-patient testing. Self-testing devices stay on paper. A mixed portfolio therefore follows two regimes.
The risk assessment, first item in the file
The regulation requires a documented risk assessment before the electronic form is chosen. It covers, among other things:
- the knowledge and experience of intended users, in particular with electronic instructions;
- the characteristics of the environment of use, including actual access to a screen and a connection;
- the compatibility of the website with the devices likely to display the instructions;
- foreseeable medical emergency situations, which may call for immediate information;
- temporary unavailability of the website and the action to be taken;
- protection against intrusion and falsification, together with version management;
- the time needed to supply paper instructions on request.
This assessment belongs to the technical documentation. Its absence, or its reduction to a generic page copied from a template, remains one of the easiest findings to raise during an audit.
Labelling: stating that the instructions are electronic, and how to reach them
The manufacturer states clearly that the instructions are supplied in electronic form rather than on paper. The information appears on the packaging of each unit, on the sales packaging, on the device itself for fixed installed devices, and at the point from which the software is accessed. The symbol pointing to the instructions defined in ISO 15223-1 (symbol 5.4.3, derived from ISO 7000-1641) serves as the standardised marker.
Three elements go with that statement: the means of access, meaning the web address or its equivalent; the minimum information needed in an emergency or for installation; and the UDI-DI, which allows the version applicable to the device in hand to be retrieved. A generic address pointing to the manufacturer's home page does not do that job.
The website: languages, versions, availability
The website hosting the instructions carries most of the compliance burden. The requirements fit into a few lines:
- the instructions are available in the official Union language or languages required by each Member State where the device is made available;
- the format can be read with freely available software;
- the website is protected against intrusion and its downtime is kept to a minimum;
- previous versions remain accessible, with their date of issue and version number;
- where several versions coexist, the link between each version and the device concerned is explicit, with the UDI-DI as the key;
- users are informed in the event of a field safety corrective action.
Since the 2025 amendment, the address of the website where the instructions are published must be provided in the EUDAMED database, in the device and UDI registration module, from the date that registration becomes mandatory.
Paper instructions on request: seven calendar days
The most operational point is also the most often underestimated. The manufacturer puts in place a system to supply the instructions on paper, at no cost to the user, within the time frame set by its risk assessment and no later than seven calendar days after the request is received. Where the request is made at the time of ordering, the paper instructions travel with the device.
Seven days means knowing who receives the request, which document is printed, in which language and in which version. That route is described in a procedure, and that procedure is auditable.
Consistency between the screen, the packaging and the file
The electronic form shifts documentation risk rather than removing it. Instructions that live on a website change faster than the rest of the file. We therefore look at four reconciliations:
- the version published online matches the one cited in the technical documentation and in the release records;
- the minimum information printed on the packaging does not contradict the full instructions, in particular warnings and contra-indications;
- the language versions say the same thing, including in compatibility tables and numerical values;
- the texts cited in the instructions are current: a reference to Regulation (EU) No 207/2012 or to a repealed directive signals an update cycle left unfinished.
These checks rely on public texts, but also on your own rules: naming conventions, version control procedure, claims matrix. Those internal frameworks can be submitted as review requirements, alongside the regulatory texts already covered, Implementing Regulation 2021/2226 included.
In practice
Before switching a set of instructions to eIFU, five questions frame the subject. Is the device intended exclusively for professional users? Is the risk assessment written, dated and attached to the file? Does the packaging state the electronic form, the means of access and the UDI-DI? Does the website hold the languages, the versions and the availability? Does the paper route fit within seven calendar days?
Document review comes next: checking that the published instructions, the packaging and the technical file tell the same story, version by version and language by language. This is the cross-check we support with EryonOne, each finding quoting the exact passage and the reference text. The report stays working material: the decision belongs to the expert who signs off.
Bibliographie
- Commission Implementing Regulation (EU) 2021/2226 of 14 December 2021 laying down rules for the application of Regulation (EU) 2017/745 as regards electronic instructions for use of medical devices, Official Journal of the European Union, 2021
- Commission Implementing Regulation (EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form, Official Journal of the European Union, 2025
- Regulation (EU) 2017/745 on medical devices, Annex I, Chapter III, Section 23, Official Journal of the European Union, 2017
- Regulation (EU) 2017/746 on in vitro diagnostic medical devices, Annex I, Chapter III, Section 20, Official Journal of the European Union, 2017
- ISO 15223-1:2021, Medical devices, Symbols to be used with information to be supplied by the manufacturer, International Organization for Standardization, 2021